Inhibition of degranulation of human polymorphonuclear leukocytes by complement factor D

No abstract is available for this paper.

• Publication year

  1995

• Venue

  FEBS Letters

• Publication date

  1995-09-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-5793(95)00926-ZPMID 7556615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nephrology Dialysis Transplantation Removal of complement factor D by adsorption on polymethylmethacrylate dialysis membranes

  2005cited by this paper
• Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment.

  1994cited by this paper
• Specific interactions of polystyrene biomaterials with factor D of human complement.

  1993cited by this paper
• Decreased activity of complement-mediated immune complex clearance in hemodialysis patients.

  1993cited by this paper
• Adsorption of complement factor D by polyacrylonitrile dialysis membranes.

  1993cited by this paper
• Fluid-phase activation of the alternative pathway of complement by excess factor D in regularly dialyzed patients.

  1992cited by this paper
• Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.

  1992cited by this paper
• Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis.

  1991cited by this paper
• Release of proteinases from stimulated polymorphonuclear leukocytes. Evidence for subclasses of the main granule types and their association with cytoskeletal components.

  1991cited by this paper
• Uremia and host defenses.

  1990cited by this paper
• Molecular and functional identification and purification of complement component factor D from urine of patients with chronic renal failure.

  1990cited by this paper
• Enzyme Linked Immunosorbent Assays (ELISA) for the Quantitative Determination of Human Leukocyte Collagenase and Gelatinase

  1989cited by this paper
• A simplification of Heukeshoven and Dernick's silver staining of proteins

  1987cited by this paper
• Renal filtration and catabolism of complement protein D.

  1985cited by this paper
• Amino acid sequence of human D of the alternative complement pathway.

  1984cited by this paper
• Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence.

  1979cited by this paper
• Mechanism of action of factor D of the alternative complement pathway

  1978cited by this paper
• Human factor D of the alternative complement pathway: purification and characterization.

  1977cited by this paper
• Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A.

  1972cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper

• Single-cell analysis of a salmonid immune system (brown trout Salmo trutta) reveals evolutionary divergence and hatchery-induced transcriptional reprogramming

  2025cites this paper
• Complement factor D as a predictor of Achilles tendon healing and long‐term patient outcomes

  2022cites this paper
• Secondary Immunodeficiency Related to Kidney Disease (SIDKD) - Definition, Unmet Need and Mechanisms.

  2021cites this paper
• Effects on the Removal of Uremic Toxins

  2016cites this paper
• Treatment Frequency and Efficiency in Hemodiafiltration

  2013cites this paper
• Chronic Kidney Disease: Pathophysiology and the Influence of Dietary Protein

  2013cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS RURAIS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA VETERINÁRIA EFEITOS DA QUERCETINA NA ATIVIDADE DA ACETILCOLINESTERASE, NA PEROXIDAÇÃO LIPÍDICA E NOS TESTES COMPORTAMENTAIS EM RATOS DIABÉTICOS INDUZIDOS POR ESTREPTOZOTOCINA

  2013cites this paper
• Isolation of genes involved in pancreas regeneration by subtractive hybridization

  2010cites this paper
• CHAPTER 93 – Chronic Kidney Disease: Pathophysiology and Influence of Dietary Protein

  2008cites this paper
• Modulation of the plasma membrane domain structure of human neutrophils

  2006cites this paper
• UNRESOLVED ISSUES IN DIALYSIS: Extracorporeal Strategies for the Removal of Middle Molecules

  2006cites this paper
• Preparation of Secretory Vesicle-Free Plasma Membranes by Isopycnic Sucrose Gradient Fractionation of Neutrophils Purified by the Gelatin Method

  2004cites this paper
• Impaired cellular host defense and chronic inflammatory abnormalities in end-stage renal disease

  2004cites this paper
• Sorbents in Acute Renal Failure and End-Stage Renal Disease: Middle Molecule and Cytokine Removal

  2004cites this paper
• A proteomic analysis of proteins removed by ultrafiltration during extracorporeal renal replacement therapy.

  2004cites this paper
• Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.

  2003cites this paper
• Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis

  2003cites this paper
• Middle molecules and small-molecular-weight proteins in ESRD: properties and strategies for their removal.

  2003cites this paper
• Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor*

  2003cites this paper
• Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.

  2002cites this paper
• Uremic Toxicity: Present State of the Art

  2001cites this paper
• Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils.

  2001cites this paper
• Natural inhibitors of neutrophil function in acute respiratory distress syndrome

  2001cites this paper
• Complement components as uremic toxins and their potential role as mediators of microinflammation.

  2001cites this paper
• Are new toxins appearing on the horizon?

  2001cites this paper
• Acquired disorders of phagocyte function complicating medical and surgical illnesses.

  2001cites this paper
• Neutrophil β2-Microglobulin and lactoferrin content in renal failure patients

  2000cites this paper
• Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients.

  2000cites this paper
• Degranulation of polymorphonuclear leukocytes by dialysis membranes--the mystery clears up?

  2000cites this paper
• Uremic toxins: new aspects.

  2000cites this paper
• Clinical significance of granulocyte-inhibiting proteins.

  2000cites this paper
• A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study.

  2000cites this paper
• Neutrophil apoptosis and dysfunction in uremia.

  1999cites this paper
• High molecular weight uremic toxins

  1998cites this paper
• Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uremic patients.

  1998cites this paper
• Genesis of the uraemic syndrome: role of uraemic toxins.

  1998cites this paper
• Immune dysfunction in uremia.

  1997cites this paper
• Leukodiapedesis, function, and physiological role of leucocyte matrix metalloproteinases.

  1997cites this paper
• Dysfunction of polymorphonuclear leukocytes in uremia.

  1996cites this paper